VeinShow MedTech srls is a new innovative start Up for production, marketing, and distribution of VeinShow Medical devices innovation.
VeinShow is a patented Medical Device that will be used for blood sampling and peripheral venous catheter fixation in newborn and children.
VeinShow is the unique medical device in the world that can, at the same time, auto-fix patient arm, has large windows free for detecting veins (no need to search veins), use controlled tourniquet, measures oxygen saturation and distract the child during blood sampling. Detect veins with profundity estimation, immediate detecting veins. For this, it can be used in an ordinary and emergency situation.

we pre-agreements with some suppliers to supply our company with the essential materials for the production of the veinshow medical device.
and pre-agreements with a partner for the assemblation.
we have our distribution channel to trade and marketing

Middle East Market size 100 M €, European market size 2 MLD€....
VeinShow MedTech srls is a new innovative start Up for production, marketing, and distribution of VeinShow Medical devices innovation.
VeinShow is a patented Medical Device that will be used for blood sampling and peripheral venous catheter fixation in newborn and children.
VeinShow is the unique medical device in the world that can, at the same time, auto-fix patient arm, has large windows free for detecting veins (no need to search veins), use controlled tourniquet, measures oxygen saturation and distract the child during blood sampling. Detect veins with profundity estimation, immediate detecting veins. For this, it can be used in an ordinary and emergency situation.

we pre-agreements with some suppliers to supply our company with the essential materials for the production of the veinshow medical device.
and pre-agreements with a partner for the assemblation.
we have our distribution channel to trade and marketing

Middle East Market size 100 M €, European market size 2 MLD€. International Market size 11 MLD €. Direct market sell cost 10 K €, indirect sell market cost 8 K €.
2nd (at least) company year income 4.5 M €, 3rd year 10.4M €, and 4th year 13 M €.
More information

Investors

BioUpper | Call for Scale
Admin
BioUpper | Call for Scale Life Sciences Training and acceleration platform
Get it | Call For Impact KETs
Admin
Get it | Call For Impact KETs Accelerator platform to facilitate social entrepreneurship

Advisors

Luca Canepa
Admin
Luca Canepa